Daily Oral Miltefosine (Hexadecyl-Phosphocholine) in Patients with Advanced Non-Small Cell Lung Cancer. A Phase II Study
| Autor: | M. Westerhausen, Wolfgang E. Berdel, P. Bachmann, Agnieszka Korfel, R. Becher, M. Klee, U. Essers, K. Bremer, M. Zafferani, Lutz Edler, A. Drozd |
|---|---|
| Rok vydání: | 1992 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty Miltefosine Pathology business.industry Phases of clinical research Hematology medicine.disease respiratory tract diseases chemistry.chemical_compound chemistry Internal medicine Medicine In patient Non small cell business Lung cancer Phosphocholine medicine.drug |
| Zdroj: | Oncology Research and Treatment. 15:238-242 |
| ISSN: | 2296-5262 2296-5270 |
| DOI: | 10.1159/000217364 |
| Popis: | A clinical phase II trial with an oral formulation of miltefosine (MIL) was performed in patients with non-small cell lung cancer (NSCLC). Eligibility criteria for this phase II study included histolo |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|